Articles
edinburgh

Access to new medicines in Scotland

Leela Barham considers the history of Scottish Medicines Consortium (SMC) drug approvals in Scotland and whether the trend is towards greater access in recent years.

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

R&D